Clinical Trial Update: Progesterone in Luteal Phase Deficiency [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating progesterone for luteal phase defect was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Luteal Phase Defect

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: IBSA Institut Biochimique SA | Conditions: Luteal Phase Defect | Phase 3 | Status: WITHDRAWN